Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Sorrento Therapeutics Inc SRNE

Healthcare Biotechnology
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G... see more

Opinion & Analysis (GREY:SRNE)

    Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition

    Streetwise Reports May 28, 2020

    2017 Small-Cap Biotech Watchlist update: up 21% at the end of Q2/17

    The Life Sciences Report July 14, 2017

    2017 Small-Cap biotech watchlist update: holding steady in a volatile market

    The Life Sciences Report April 21, 2017

    2017 Small-Cap Biotech Watchlist: takeaways for investors

    The Life Sciences Report January 19, 2017

    19 companies selected for the 2017 Small-Cap Biotech Watchlist

    The Life Sciences Report January 5, 2017

    Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

    The Life Sciences Report March 11, 2016

    Immunotherapy Inside the Cell: Three Companies on Their Way to the 'Holy Grail' of Cancer Treatment

    The Life Sciences Report January 6, 2016

    CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

    Gail Dutton September 10, 2015

    VIDEO: Sorrento Therapeutics developing new treatments for cancer and associated pain

    BTV-Business Television November 5, 2014

    VIDEO: Sorrento Therapeutics A Biotech Innovator Fast Tracking An Oncology Drug

    BTV-Business Television June 25, 2014